JohnDavidSzumowskiMDMPH
Infectious Disease • San Francisco, CAHIV/AIDS Medicine, Mycobacterial Disease
Associate Clinical Professor, UCSF/San Francisco VA
Dr. Szumowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 Clement St
6TH floor
San Francisco, CA 94121Phone+1 415-221-4810
Summary
- I am an Infectious Diseases specialist with training in both public health and laboratory science, and experience working collaboratively in India and South Africa. My clinical interests within ID are broad, although I have a particular interest in care of persons with HIV and TB.
Education & Training
University of WashingtonFellowship, Infectious Disease, 2010 - 2014
U Washington Affil Hosps2010 - 2014
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2007 - 2010
Harvard Medical SchoolClass of 2007
Certifications & Licensure
CA State Medical License 2013 - 2025
WA State Medical License 2010 - 2016
MA State Medical License 2009 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Merle Sande Fellowship in International Infectious Diseases Infectious Diseases Society of America, 2012
Publications & Presentations
PubMed
- 4 citations48-week viral suppression rates in people with HIV starting long-acting CAB/RPV with initial viremia.Matthew D Hickey, Nathanael Gistand, Janet Grochowski, Francis Mayorga-Munoz, Elizabeth Imbert
Clinical Infectious Diseases. 2024-10-05 - 4 citationsIdentifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally Unsuppressed.Matthew D Hickey, Janet Grochowski, Francis Mayorga-Munoz, Jon Oskarsson, Elizabeth Imbert
Journal of Acquired Immune Deficiency Syndromes. 2024-07-01 - 1 citationsExperience With Four-Month Rifapentine and Moxifloxacin-Based Tuberculosis Treatment in San Francisco.Janice K Louie, Rocio Agraz-Lara, Gustavo E Velásquez, Allison Phillips, John D Szumowski
Open Forum Infectious Diseases. 2024-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
